...
首页> 外文期刊>Journal of clinical periodontology >Guided tissue regeneration combined with a deproteinized bovine bone mineral (Bio-Oss~R) in the treatment of intrabony periodontal defects: 6-year results from a randomized-controlled clinical trial
【24h】

Guided tissue regeneration combined with a deproteinized bovine bone mineral (Bio-Oss~R) in the treatment of intrabony periodontal defects: 6-year results from a randomized-controlled clinical trial

机译:引导性组织再生结合脱蛋白的牛骨矿物质(Bio-Oss〜R)治疗骨内牙周缺损:一项随机对照临床试验的6年结果

获取原文
获取原文并翻译 | 示例
           

摘要

Aim: To present the 6-year results of a randomized-controlled clinical trial evaluating guided tissue regeneration (GTR) combined with or without deproteinized bovine bone mineral (DBBM) in intrabony defects.Material & Methods: In each of 45 patients, one defect was treated with GTR combined with DBBM hydrated in saline (DBBM -) or gentamicin sulphate (DBBM+) or with GTR alone. Clinical parameters were recorded pre-surgery, at 1 and 6 years postsurgery. Results: Thirty-six patients/33 teeth were available for the 6-year control. Statistically significant clinical improvements were observed for all treatments. Clinical attachment level (CAL) gain averaged 2.5 mm (DBBM - ), 4.1 mm (DBBM+), and 3.0 mm (GTR) at 1 year postsurgery, and remained stable over 5 additional years (2.3, 4.1, and 2.7 mm, respectively). Treatment did not appear to influence residual probing depths (PDs) or CAL gains at 6 years postsurgery, or the extent of PD and CAL change from 1 to 6 years, and did not associate with sites losing CAL during follow-up. No association of grafting with sites showing CAL gain >=4 mm at the 1- or 6-year control was observed. Conclusion: The improvements in periodontal conditions obtained after GTR treatment with or without the adjunct use of DBBM can be preserved on a long-term basis.
机译:目的:提出一项随机对照临床试验的6年结果,该试验评估在有骨缺损中结合或不结合去蛋白牛骨矿物质(DBBM)进行的引导组织再生(GTR)。材料与方法:45例患者中的每一个均存在一个缺陷将GTR与在盐水(DBBM-)或硫酸庆大霉素(DBBM +)中水合的DBBM结合或单独与GTR一起治疗。术前,术后1年和6年记录临床参数。结果:36例患者/ 33颗牙齿可用于6年对照。在所有治疗中均观察到统计学上显着的临床改善。术后1年平均临床附着水平(CAL)增益平均为2.5毫米(DBBM-),4.1毫米(DBBM +)和3.0毫米(GTR),并且在接下来的5年中保持稳定(分别为2.3、4.1和2.7毫米) 。治疗似乎并未影响术后6年的残余探测深度(PDs)或CAL的增加,或PD和CAL从1到6年变化的程度,并且与随访期间失去CAL的部位无关。在1年或6年对照组中,未观察到嫁接与显示CAL增益> = 4 mm的位点相关。结论:GTR治疗后,无论是否使用DBBM,均可长期保持牙周病的改善。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号